Literature DB >> 20632513

[Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation].

Tingjie Chang1, Kanglai Tang, Xu Tao, Honghui Cao, Hui Li, Qianbo Chen, Lei Chen, Jianbo Zhou, Binghua Zhou, Jianzhong Xu.   

Abstract

OBJECTIVE: To compare the clinical outcomes of the core decompression combined with autologous bone marrow mesenchymal stem cells (BMSCs) transplantation with the isolated core decompression for the treatment of early avascular necrosis of the femoral head (ANFH).
METHODS: From May 2006 to October 2008, 8 patients (16 hips) with early ANFH were treated. There were 7 males and 1 female with an average age of 35.7 years (range, 19-43 years). According to the system of the Association Research Circulation Osseous (ARCO): 4 hips were classified as stage II a, 2 as stage II b, 1 as stage II c, and 1 as stage III a in group A; 2 hips were classified as stage II a, 2 as stage II b, 3 as stage II c, and 1 as stage III a in group B. The average disease course was 1.1 years (range, 4 months to 2 years). The patients were randomly divided into 2 groups according to left or right side: group A, only the core decompression was used; group B, both the core decompression and autologous BMSCs transplantation were used. The Harris score and visual analogue scale (VAS) score were determined, imaging evaluation was carried out by X-rays and MRI pre- and post-operatively. The erythrocyte sedimentation rate, C-reactive protein, liver function, renal function, and immunoglobulin were detected for safety evaluation.
RESULTS: All incisions healed by first intention. Eight patients were followed up 12-42 months (23.5 months on average). The clinical symptoms of pain and claudication were gradually improved. The Harris scores and VAS scores of all patients were increased significantly at 3, 6, and 12 months after operation (P < 0.05). There was no significant difference between groups A and B 3 and 6 months after operation (P > 0.05), but there was significant difference between groups A and B 12 months after operation (P < 0.05). The necrosis area of femoral head in groups A and B were 18.13% +/- 2.59% and 13.25% +/- 2.12%, respectively, showing significant difference (P < 0.05). In group A, femoral head collapsed 12 months after operation in 1 case of stage III. No complication of fever, local infection
CONCLUSION: The core decompression and the core decompression combined with BMSCs transplantation are both occurred. effective for the treatment of early ANFH. The core decompression combined with BMSCs transplantation is better than core decompression in the relief of pain and postponing head collapse.

Entities:  

Mesh:

Year:  2010        PMID: 20632513

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  12 in total

Review 1.  Therapeutic application of mesenchymal stem cells in bone and joint diseases.

Authors:  Yi Liu; Jianmei Wu; Youming Zhu; Jinxiang Han
Journal:  Clin Exp Med       Date:  2012-11-03       Impact factor: 3.984

Review 2.  Are we evaluating osteonecrosis adequately?

Authors:  Gwo-Chin Lee; Marvin E Steinberg
Journal:  Int Orthop       Date:  2012-09-26       Impact factor: 3.075

Review 3.  Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head.

Authors:  Cheng Wang; Yu Wang; Hao-Ye Meng; Xue-Ling Yuan; Xiao-Long Xu; Ai-Yuan Wang; Quan-Yi Guo; Jiang Peng; Shi-Bi Lu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Stem Cell Therapy for Osteonecrosis of the Femoral Head: Current Trends and Comprehensive Review.

Authors:  Lei Zhao; Alan David Kaye; Aaron J Kaye; Alaa Abd-Elsayed
Journal:  Curr Pain Headache Rep       Date:  2018-05-03

Review 5.  Surgical management of osteonecrosis of the femoral head in patients with sickle cell disease.

Authors:  Atul F Kamath; Michael H McGraw; Craig L Israelite
Journal:  World J Orthop       Date:  2015-11-18

6.  Clinical outcomes of osteonecrosis of the femoral head after autologous bone marrow stem cell implantation: a meta-analysis of seven case-control studies.

Authors:  Heng-Feng Yuan; Jing Zhang; Chang-An Guo; Zuo-Qin Yan
Journal:  Clinics (Sao Paulo)       Date:  2016-02       Impact factor: 2.365

Review 7.  Autologous Stem Cells Combined Core Decompression for Treatment of Avascular Necrosis of the Femoral Head: A Systematic Meta-Analysis.

Authors:  Shibing Xu; Lei Zhang; Hongting Jin; Letian Shan; Li Zhou; Luwei Xiao; Peijian Tong
Journal:  Biomed Res Int       Date:  2017-08-03       Impact factor: 3.411

Review 8.  Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.

Authors:  Ratti Ram Sharma; Kathryn Pollock; Allison Hubel; David McKenna
Journal:  Transfusion       Date:  2013-10-16       Impact factor: 3.157

9.  Use of concentrated bone marrow aspirate and platelet rich plasma during minimally invasive decompression of the femoral head in the treatment of osteonecrosis.

Authors:  John R Martin; Matthew T Houdek; Rafael J Sierra
Journal:  Croat Med J       Date:  2013-06       Impact factor: 1.351

Review 10.  Stem cell treatment for avascular necrosis of the femoral head: current perspectives.

Authors:  Matthew T Houdek; Cody C Wyles; John R Martin; Rafael J Sierra
Journal:  Stem Cells Cloning       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.